Camden National (CAC) director receives 919-share equity award, now holds 14,512

Rhea-AI Filing Summary

Longley S. Catherine reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp director Catherine S. Longley received an equity award of 919 shares of Common Stock under the company’s Independent Directors' Equity Compensation Program, part of the 2022 Equity and Incentive Plan and Amendment. The grant carried no purchase price and vested immediately on the grant date.

Following this award, Longley directly holds a total of 14,512.613 shares of Camden National Corp common stock. This filing reflects routine director compensation rather than an open-market stock purchase or sale.

Insights

Equity compensation analyst

Routine equity grant increases director’s direct share holdings.

Catherine S. Longley, a director of Camden National Corp, received 919 shares of Common Stock as a stock grant under the Independent Directors' Equity Compensation Program. The grant was made at no cash cost to her and vested immediately.

This is a standard, compensation-related Form 4 event rather than an open-market transaction. After the grant, Longley holds 14,512.613 shares directly, which modestly increases her equity exposure and aligns her incentives with shareholders through additional stock ownership.

Insider Trade Summary

Net Buyer: 919 shares

Net Buy 1 txn

Insider Longley S. Catherine

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	919	$0.00	$0.00

Holdings After Transaction: Common Stock — 14,512.613 shares (Direct)

Footnotes (1)

1. F1. Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A. These shares vested immediately on the date of the grant.

Key Figures

Shares granted: 919 shares Post-grant holdings: 14,512.613 shares Grant price: $0.0000 per share +1 more

4 metrics

Shares granted 919 shares Equity award of Common Stock to director on grant date

Post-grant holdings 14,512.613 shares Director’s direct Common Stock ownership following the grant

Grant price $0.0000 per share Stated price for the compensation-related stock grant

Transactions acquiring shares 1 transaction Single grant/award acquisition reported in this Form 4

Key Terms

Independent Directors' Equity Compensation Program, 2022 Equity and Incentive Plan and Amendment, Common Stock, Form 4

4 terms

Independent Directors' Equity Compensation Program financial

"Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment"

2022 Equity and Incentive Plan and Amendment financial

"a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A"

Common Stock financial

"Catherine S. Longley received an equity award of 919 shares of Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"This is a standard, compensation-related Form 4 event rather than an open-market transaction."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/03/2026 - 04:33 PM Accepted by SEC EDGAR 06/03/2026 - 04:31 PM Learn about SEC filing dates

FAQ

What did Camden National Corp (CAC) director Catherine S. Longley report in this Form 4?

Catherine S. Longley reported receiving a grant of 919 shares of Camden National Corp Common Stock. The award was part of the Independent Directors' Equity Compensation Program and vested immediately, increasing her direct ownership to 14,512.613 shares after the transaction.

Was the Camden National Corp (CAC) Form 4 transaction a market purchase or sale?

The Form 4 transaction was not a market purchase or sale. It was an equity grant coded as a grant, award, or other acquisition, given at a price of $0.0000 per share as part of the company’s Independent Directors' Equity Compensation Program.

How many Camden National Corp (CAC) shares did the director receive and at what price?

The director received 919 shares of Camden National Corp Common Stock at a stated price of $0.0000 per share. According to the footnote, these shares were granted under an equity compensation program, so the price is described as not applicable rather than a trading price.

What is Catherine S. Longley’s total Camden National Corp (CAC) holding after this grant?

After the equity grant, Catherine S. Longley directly holds 14,512.613 shares of Camden National Corp Common Stock. This total reflects her position following the addition of 919 shares granted under the Independent Directors' Equity Compensation Program on the reported grant date.

What plan governed the equity grant reported for Camden National Corp (CAC) director Longley?

The equity grant was made under the Independent Directors' Equity Compensation Program, which is a component of Camden National Corp’s 2022 Equity and Incentive Plan and Amendment. The footnote states that these shares vested immediately on the grant date under this plan framework.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Longley S. Catherine

(Last) (First) (Middle)

2 ELM STREET

P.O. BOX 310

(Street)

CAMDEN MAINE 04843

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		A		919	A	$0(1)	14,512.613	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A. These shares vested immediately on the date of the grant.

Remarks:

	Christopher G. Hutchinson, POA	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)